EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association between insulin resistance and prostate volume: A 4‐year analysis from the Reduction by Dutasteride of Prostate Cancer (REDUCE) Trial

James P Daniels, Alexander Hernández-Tirado iD, James Mirocha, Renning Zheng, Jordan Palmer, Daniel Moreira, Stephen J Freedland iD

BJUI Compass · 2025-09 · 6 (9)

DOI: 10.1002/bco2.70085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJUI Compass, online erschienen am 14.09.2025. Verfasst von James P Daniels und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology University of Louisville Louisville Kentucky USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Most, but not all studies, suggest insulin resistance is associated with benign prostatic hyperplasia, but its impact on prostate volume (PV) changes over time remains unclear. We examined whether higher insulin resistance, measured by Homeostatic Model Assessment of Insulin Resistance (HOMA‐IR), is associated with larger PV and greater prostate growth over a 4‐year period. Materials and Methods We analysed data from the 4‐year, randomized, double‐blind, placebo‐controlled REDUCE trial testing whether dutasteride could prevent prostate cancer. Patients underwent transrectal ultrasound measuring PV at baseline, year 2 and year 4. We calculated HOMA‐IR from baseline fasting glucose and insulin, then stratified patients into quartiles within each arm (placebo vs. dutasteride). Using multivariable models, we estimated PV changes over time. We conducted a sensitivity analysis excluding patients with diabetes.

Results

Higher HOMA‐IR quartiles were associated with larger PV at baseline, year 2 and year 4 in both placebo and dutasteride arms (all p < 0.001), though absolute differences were modest. PV increased in the placebo arm over 4 years, whereas it decreased in the dutasteride arm. However, there was no significant association between HOMA‐IR and PV change in either arm. Results remained unchanged after excluding patients with diabetes.

Conclusion

Patients with higher HOMA‐IR had modestly larger PVs at baseline, year 2 and year 4, but insulin resistance was unrelated to PV change over four years. These findings suggest that insulin resistance may be a modifiable risk factor contributing to benign prostatic enlargement, though further research is needed to determine its clinical relevance.

Schlagwörter

Stichwörter der Autor:innen

Benign Prostatic HyperplasiaHOMA‐IRInsulin ResistanceProstate GrowthProstate VolumeREDUCE Trial

Autor:innen und Institutionen

  • Department of Urology University of Louisville Louisville Kentucky USA.
  • Department of Urology Cedars-Sinai Medical Center Los Angeles CA USA.
  • Samuel Oschin Comprehensive Cancer Institute Cedars-Sinai Medical Center California Los Angeles USA.
  • Clinical and Translational Science Institute Cedars-Sinai Medical Center California Los Angeles USA.
  • School of Medicine, Tsinghua Medicine Tsinghua University Beijing China.
  • A.T. Still University College of Osteopathic Medicine Kirskville MO USA.

ORCID-Profile: Alexander Hernández-Tirado, Stephen J Freedland

Förderung

  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences

Zitieren

APA

Daniels, J. P., Hernández-Tirado, A., Mirocha, J., Zheng, R., Palmer, J., Moreira, D., & Freedland, S. J. (2025). Association between insulin resistance and prostate volume: A 4‐year analysis from the Reduction by Dutasteride of Prostate Cancer (REDUCE) Trial. BJUI Compass, 6(9). https://doi.org/10.1002/bco2.70085

Vancouver

Daniels JP, Hernández-Tirado A, Mirocha J, Zheng R, Palmer J, Moreira D, et al. Association between insulin resistance and prostate volume: A 4‐year analysis from the Reduction by Dutasteride of Prostate Cancer (REDUCE) Trial. BJUI Compass. 2025;6(9). doi:10.1002/bco2.70085

BibTeX
@article{Daniels2025,
  author = {Daniels, James P and Hernández-Tirado, Alexander and Mirocha, James and Zheng, Renning and Palmer, Jordan and Moreira, Daniel and Freedland, Stephen J},
  title = {Association between insulin resistance and prostate volume: A 4‐year analysis from the Reduction by Dutasteride of Prostate Cancer (REDUCE) Trial},
  journal = {BJUI Compass},
  year = {2025},
  volume = {6},
  number = {9},
  doi = {10.1002/bco2.70085}
}
Kostenlos starten →